| 1 |
33971703 | Enrichment of Wee1/CDC2 and NF-κB Signaling Pathway Constituents Mutually Contributes to CDDP Resistance in Human Osteosarcoma. | 2022 Jan |
4 |
| 2 |
35505963 | miR-6077 promotes cisplatin/pemetrexed resistance in lung adenocarcinoma via CDKN1A/cell cycle arrest and KEAP1/ferroptosis pathways. | 2022 Jun 14 |
1 |
| 3 |
34789301 | Ghrelin enhances cisplatin sensitivity in HO-8910 PM human ovarian cancer cells. | 2021 Nov 17 |
2 |
| 4 |
32944399 | An ATF24 peptide-functionalized β-elemene-nanostructured lipid carrier combined with cisplatin for bladder cancer treatment. | 2020 Aug 15 |
1 |
| 5 |
33336716 | Long noncoding RNA OR3A4 promotes cisplatin resistance of non-small cell lung cancer by upregulating CDK1. | 2020 Dec |
1 |
| 6 |
31059083 | Tranilast enhances the effect of anticancer agents in osteosarcoma. | 2019 Jul |
1 |
| 7 |
31173293 | Long noncoding RNA OR3A4 promotes cisplatin resistance of non-small cell lung cancer by upregulating CDK1. | 2019 May |
2 |
| 8 |
29245943 | Saikosaponin-d, a calcium mobilizing agent, sensitizes chemoresistant ovarian cancer cells to cisplatin-induced apoptosis by facilitating mitochondrial fission and G2/M arrest. | 2017 Nov 21 |
2 |
| 9 |
25376608 | The protein phosphatase 2A inhibitor LB100 sensitizes ovarian carcinoma cells to cisplatin-mediated cytotoxicity. | 2015 Jan |
1 |
| 10 |
25625243 | Cisplatin resistance in human lung cancer cells is linked with dysregulation of cell cycle associated proteins. | 2015 Mar 1 |
5 |
| 11 |
26396928 | Synergistic effect of allyl isothiocyanate (AITC) on cisplatin efficacy in vitro and in vivo. | 2015 |
1 |
| 12 |
24327015 | An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma. | 2014 Jan 21 |
1 |
| 13 |
24365782 | Abrogating G₂/M checkpoint through WEE1 inhibition in combination with chemotherapy as a promising therapeutic approach for mesothelioma. | 2014 Apr |
2 |
| 14 |
24756776 | Cisplatin-induced senescence in ovarian cancer cells is mediated by GRP78. | 2014 Jun |
4 |
| 15 |
22355465 | BCL2 antagonist of cell death kinases, phosphatases, and ovarian cancer sensitivity to cisplatin. | 2012 Jan |
1 |
| 16 |
20195699 | Thioredoxin reductase inhibitor ethaselen increases the drug sensitivity of the colon cancer cell line LoVo towards cisplatin via regulation of G1 phase and reversal of G2/M phase arrest. | 2011 Aug |
1 |
| 17 |
21570766 | RasGAP-derived peptide 38GAP potentiates the cytotoxicity of cisplatin through inhibitions of Akt, ERK and NF-κB in colon carcinoma HCT116 cells. | 2011 Sep 1 |
1 |
| 18 |
21592546 | The impact of S- and G2-checkpoint response on the fidelity of G1-arrest by cisplatin and its comparison to a non-cross-resistant platinum(IV) analog. | 2011 Aug |
2 |
| 19 |
20655883 | Polo-like kinase1 (Plk1) knockdown enhances cisplatin chemosensitivity via up-regulation of p73α in p53 mutant human epidermoid squamous carcinoma cells. | 2010 Nov 1 |
1 |
| 20 |
15868412 | Antiproliferative effect of beta-elemene in chemoresistant ovarian carcinoma cells is mediated through arrest of the cell cycle at the G2-M phase. | 2005 Apr |
2 |
| 21 |
15386387 | Aberrant p53 alters DNA damage checkpoints in response to cisplatin: downregulation of CDK expression and activity. | 2004 Dec 10 |
1 |
| 22 |
11093360 | Flavopiridol, the first cyclin-dependent kinase inhibitor to enter the clinic: current status. | 2000 Dec |
1 |
| 23 |
9688315 | Contribution of the cyclin-dependent kinase inhibitor p27KIP1 to the confluence-dependent resistance of HT29 human colon carcinoma cells. | 1998 Aug 31 |
1 |
| 24 |
9743457 | Cisplatin-induced inhibition of p34cdc2 is abolished by 5-fluorouracil. | 1998 |
2 |
| 25 |
7574801 | [Cell cycle regulation by anticancer agent]. | 1995 Oct |
1 |
| 26 |
8109984 | [Effect of cisplatin on cell cycle regulators]. | 1994 Feb |
5 |
| 27 |
8406990 | Cis-diamminedichloroplatinum(II) inhibits p34cdc2 protein kinase in human lung-cancer cells. | 1993 Oct 21 |
8 |